Michael Deininger, Lesly Dossett, Samuel Kaffenberger join Rogel Cancer Center leadership

The Alliance for Clinical Trials in Oncology appoints new committee leaders

The Alliance for Clinical Trials in Oncology has named new investigators to leadership roles across its Immuno-Oncology, Radiation Oncology, and Imaging Committees. These accomplished leaders bring expertise spanning immunotherapy, breast, and brain cancers, precision radiotherapy, and advanced imaging technologies.

November 07, 2025

Vol.51 No.41

In Brief

Azeddine Atfi, Elizabeth Cunningham, Benjamin Herring appointed to Karmanos leadership

Azeddine AtfiElizabeth CunninghamBenjamin HerringThe Barbara Ann Karmanos Cancer Institute has appointed Azeddine Atfi as deputy center director of research, Elizabeth Cunningham as vice president of the Karmanos Cancer Institute Clinical Trials Office, and Benjamin Herring as vice president and associate center director of research administration.

November 07, 2025

Vol.51 No.41

In Brief

Richard Schulick named chief clinical officer at University of Rochester Medical Center

Richard Schulick was named chief clinical officer at University of Rochester Medical Center, effective in April 2026.

November 07, 2025

Vol.51 No.41

In Brief

Jonathan Licht named president, chief scientific officer at Van Andel Institute

Jonathan D. Licht was named president and chief scientific officer of the Van Andel Institute. Licht will begin his new role in early 2026.

October 31, 2025

Vol.51 No.40

In Brief

Vinai Gondi, Bridget Koontz, Priya Rastogi, Lisa Lenrow named to NRG Oncology committee leadership

Vinai GondiBridget KoontzPriya RastogiLisa LenrowNRG Oncology, an NCI National Clinical Trials Network group focused on improving outcomes for adults with cancer through multi-center clinical research, recently announced changes in leadership across multiple committees.

October 31, 2025

Vol.51 No.40

In Brief

Eytan Ruppin named deputy director of Translational Research Institute at Cedars-Sinai

Eytan Ruppin, a data scientist who works with AI-based methods for predicting individual patients’ response to cancer therapies, has joined Cedars-Sinai Cancer as deputy director of the Translational Research Institute. He will also serve as director of Integrative Data Sciences in the Division of Surgical Research.

October 31, 2025

Vol.51 No.40

Michael Deininger, Lesly Dossett, Samuel Kaffenberger join Rogel Cancer Center leadership

YOU MAY BE INTERESTED IN

The Alliance for Clinical Trials in Oncology appoints new committee leaders

Azeddine Atfi, Elizabeth Cunningham, Benjamin Herring appointed to Karmanos leadership

Richard Schulick named chief clinical officer at University of Rochester Medical Center

Jonathan Licht named president, chief scientific officer at Van Andel Institute

Vinai Gondi, Bridget Koontz, Priya Rastogi, Lisa Lenrow named to NRG Oncology committee leadership

Eytan Ruppin named deputy director of Translational Research Institute at Cedars-Sinai

Renew today!

Subscriber content

Never miss an issue!

Login